Stock screenerAll disclosures →
EDGAR →
RCEL
Conviction 96HealthcareScan · Mon, Aug 10, 2026RCEL$7.60-2.19%
ResistanceSupportVol 14Insider buy2
Vol MA14 850.56K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price7.60
Change-2.19%
Gap+0.00%
Rel volume4.67×
Avg volume709.37K
Avg $ vol4.87M
SMA 204.99
SMA 504.53
SMA 2004.19
Price vs 50+67.70%
Price vs 200+81.19%
MA stackbullish
50/200 cross—
Supertrendup · 5.88
RSI (14)78
MACD hist0.29
MACD crossbull · 1d
Stoch %K / %D84 / 74
ADX (14)23
+DI / −DI54 / 13
RSI divergence—
MACD divergence—
ATR %+7.50%
ADR %8.85%
52w high7.77
52w low3.27
From 52w high-2.19%
Above 52w low+132.42%
New 52w highNo
SqueezeOff
Bollinger width75.20%
%B1.20
Donchian pos85.56%
Donchian high8.22
Donchian low3.93
AVWAP (52w high)7.75
vs AVWAP high-1.89%
AVWAP (52w low)5.02
vs AVWAP low+51.33%
OBV trendUp
Chaikin MF (20)0.25
Today vs 20d4.67×
Avg vol (14d)850.56K
Avg vol (20d)709.37K
Avg $ vol (20d)4.87M
Market cap235.04M
RS 3m (vs SPY)+80.19%
RS 6m (vs SPY)+83.60%
RS line new highYes
Trend template7/8
Technical rank97.0
1 week+64.50%
1 month+87.19%
3 months+84.91%
6 months+94.87%
1 year+41.26%
YTD+119.02%
P/E-4.84
P/B-8.44
P/S3.28
P/FCF-7.30
EPS-1.74
Div yield—
ROE174.53%
ROA-101.70%
Debt/Eq-1.68
Current0.41
EV/EBITDA-6.78
Gross margin82.13%
Net margin-67.85%
Rev growth11.45%
EPS growth21.44%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value272.56M
Revenue21.7M
Net income-7.66M
Gross profit17.77M
Free cash flow-32.2M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out30.78M
Employees226
ListedThu, Mar 8, 2012
Free float30.03M
Float %97.6%
Short interest2.62M
Days to cover7.8d
Short volume60.5%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction96 / 100
Pattern quality—
Tech rank97.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.49
Support3.77
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RCEL
No recent disclosed trades by Congress in RCEL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RCEL · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
O'Toole David D CFO · Common Stock · 2026-06-12 | Grant | 2K | $8K | 2026-06-12 | 2026-06-12 |
Woody Joseph Fralin Director · Common Stock · 2026-06-09 | Buy | 5.2K | $21K | 2026-06-09 | 2026-06-10 |
Woody Joseph Fralin Director · Common Stock · 2026-06-09 | Buy | 5K | $21K | 2026-06-09 | 2026-06-09 |
Woody Joseph Fralin Director · Common Stock · 2026-06-03 | Buy | 5K | $20K | 2026-06-03 | 2026-06-05 |
McNamara Robert Director · Common Stock · 2026-01-20 | Grant | 22.21K | — | 2026-01-20 | 2026-06-04 |
REED JAN STERN Director · Common Stock · 2026-01-20 | Grant | 22.21K | — | 2026-01-20 | 2026-06-04 |
Tarnoff Michael E Director · Stock Options (Right to Buy) · 2026-01-20 | Grant | 16.13K | $0 | 2026-01-20 | 2026-06-04 |
COOK JEREMY CURNOCK Director · Common Stock · 2026-01-20 | Grant | 22.21K | — | 2026-01-20 | 2026-06-04 |
Tarnoff Michael E Director · Common Stock · 2026-01-20 | Grant | 22.21K | — | 2026-01-20 | 2026-06-04 |
REED JAN STERN Director · Stock Options (Right to Buy) · 2026-01-20 | Grant | 16.13K | $0 | 2026-01-20 | 2026-06-04 |
SEC filings
EDGAR filings in RCEL · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.